Literature DB >> 12049488

Protein binding predictions in infants.

Patrick J McNamara1, Jane Alcorn.   

Abstract

Plasma binding protein levels are lower in the newborn than in the adult and gradually increase with age. At birth, human serum albumin (HSA) concentrations are close to adult levels (75%-80%), while alpha 1-acid glycoprotein (AAG) is initially half the adult concentration. As a result, the extent of drug binding to HSA is closer to that of the adult than are those drugs bound largely to AAG. A model that incorporates the fraction unbound in adults and the ratio of the binding protein concentration between infants and adults successfully predicted the fraction unbound in infants and children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049488      PMCID: PMC2751289          DOI: 10.1208/ps040104

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  78 in total

1.  Influence of age on serum protein binding of propranolol.

Authors:  R Bendayan; J A Pieper; R B Stewart; G J Caranasos
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

3.  Studies with stable isotopes II: Phenobarbital pharmacokinetics during monotherapy.

Authors:  T R Browne; J E Evans; G K Szabo; B A Evans; D J Greenblatt
Journal:  J Clin Pharmacol       Date:  1985 Jan-Feb       Impact factor: 3.126

4.  The pharmacokinetics of sufentanil in surgical patients.

Authors:  J G Bovill; P S Sebel; C L Blackburn; V Oei-Lim; J J Heykants
Journal:  Anesthesiology       Date:  1984-11       Impact factor: 7.892

5.  Protein binding of carbamazepine and its epoxide in maternal and fetal plasma at delivery: comparison to other anticonvulsants.

Authors:  W Kuhnz; R Steldinger; H Nau
Journal:  Dev Pharmacol Ther       Date:  1984

6.  The effect of increasing age on thiopental disposition and anesthetic requirement.

Authors:  T D Homer; D R Stanski
Journal:  Anesthesiology       Date:  1985-06       Impact factor: 7.892

7.  Cloxacillin absorption and disposition in cystic fibrosis.

Authors:  M Spino; R P Chai; A F Isles; J J Thiessen; A Tesoro; R Gold; S M MacLeod
Journal:  J Pediatr       Date:  1984-11       Impact factor: 4.406

8.  The pharmacokinetics of thiopental in pediatric surgical patients.

Authors:  S Sorbo; R J Hudson; J C Loomis
Journal:  Anesthesiology       Date:  1984-12       Impact factor: 7.892

9.  Single-dose ceftriaxone kinetics in the newborn.

Authors:  U B Schaad; W L Hayton; K Stoeckel
Journal:  Clin Pharmacol Ther       Date:  1985-05       Impact factor: 6.875

10.  Naloxone protein binding in adult and foetal plasma.

Authors:  L A Asali; K F Brown
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more
  61 in total

1.  Amikacin maturation model as a marker of renal maturation to predict glomerular filtration rate and vancomycin clearance in neonates.

Authors:  Wei Zhao; Valérie Biran; Evelyne Jacqz-Aigrain
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

2.  Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model.

Authors:  Feng Yang; Xianping Tong; D Gail McCarver; Ronald N Hines; Daniel A Beard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-06-07       Impact factor: 2.745

3.  Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?

Authors:  Sven Björkman
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.

Authors:  Esther Encinas; Rosario Calvo; John C Lukas; Valvanera Vozmediano; Monica Rodriguez; Elena Suarez
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

5.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.

Authors:  Zufei Zhang; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-01-03       Impact factor: 3.922

Review 6.  State-of-the-Art Review on Physiologically Based Pharmacokinetic Modeling in Pediatric Drug Development.

Authors:  Venkata Yellepeddi; Joseph Rower; Xiaoxi Liu; Shaun Kumar; Jahidur Rashid; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2019-01       Impact factor: 6.447

Review 7.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  A mechanistic approach for the scaling of clearance in children.

Authors:  Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 9.  Developmental pharmacokinetics in pediatric populations.

Authors:  Hong Lu; Sara Rosenbaum
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

10.  Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin.

Authors:  Pankaj K Sethi; Catherine A White; Brian S Cummings; Ronald N Hines; Srinivasa Muralidhara; James V Bruckner
Journal:  Pediatr Res       Date:  2015-11-16       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.